1/4
Looks like no tags are added yet.
Semaglutinide (Ozempic)
Supports insulin release by GLP-1 to promote fullness
Pembrolizumab (Keytruda)
Blocks PD-1 inhibition on T cells to enhance immune response against cancer.
Mitapavat (Pyrukynd/Aqvesme)
Increases red blood cell production of ATP by making pyruvate kinase more active.
Deucravactinib (Sotyktu)
Inhibits TYK2 to treat plaque psoriasis.
Baricitinib (Olumiant)
Inhibits JAK1 and JAK2 to treat moderate to severe rheumatoid arthritis.